SCHOFIELD, Wis., Jan. 4, 2010 (GLOBE NEWSWIRE) -- PuraMed BioScience (OTCBB:PMBS) announced today that it has begun to generate revenue for the first time as a result of its e-commerce website, www.MyMigraineGone.com, and direct response commercial featuring LipiGesic(TM) M, a non-prescription medication for migraine headaches.
"We are very pleased with how strong the initial results have been from our test launch of the direct response commercial," said PuraMed BioScience CEO Russell Mitchell. "We are now for the first time generating revenue and have truly begun to create awareness for our product and Company. We continue to accelerate our testing by identifying additional key markets and stations to further test our commercial," added Mitchell.
The commercial was first launched the week of Dec. 14 and will continue to air in select test markets before launching a major national direct response campaign.
The commercial is available for viewing on the corporate website at www.PuraMedBioScience.com. Click on the "Investor" tab, then the "Promotional Media" tab to view.
In addition to calling the toll-free number in the commercial to purchase LipiGesic(TM) M, orders can be placed through PuraMed's new e-commerce website, www.MyMigraineGone.com.
About the Company:
PuraMed BioScience, Inc. engages in the research, development and marketing of non-prescription medicinal and healthcare products. In addition to its leading product LipiGesic(TM) M, which provides acute relief from migraine headaches, the Company also has plans to launch LipiGesic(TM) PM that provides a remedy for insomnia and other sleep disorders as well as LipiGesic(TM) H for common tension headaches. For more information on PuraMed, visit the Company website at www.PuraMedBioScience.com, join the Company's group page on Facebook by searching "PuraMed BioScience" and follow the Company on Twitter at www.twitter.com/puramed.
Forward-Looking Statements:
This news release contains forward-looking statements regarding PuraMed BioScience and its future business plans, which statements involve known and unknown risks and uncertainties. Such risks and uncertainties may cause actual results and future achievements of PuraMed BioScience to be materially different than those implied by these forward-looking statements. PuraMed BioScience has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events.